
Join to View Full Profile
1521 Hickory Flat HwySuite 100Canton, GA 30115
Phone+1 770-479-1870
Fax+1 770-479-9705
Dr. Dhillon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2009
- U Texas MD Anderson Cancer CtrInvestigational Cancer Therapeutics, 2005 - 2007
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2005
- University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2004
- Government Medical College ChandigrahClass of 1997
Certifications & Licensure
- GA State Medical License 2009 - 2027
- CA State Medical License 2007 - 2025
- TX State Medical License 2005 - 2009
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye Start of enrollment: 2010 Jun 01
- A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer Start of enrollment: 2010 Dec 01
- Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 141 citationsPrevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a si...Hope S. Rugo, Lasika Seneviratne, J. Thaddeus Beck, John A. Glaspy, Julio A Peguero
The Lancet. Oncology. 2017-05-01 - 198 citationsDevelopment of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous MelanomaPedram Gerami, Robert W. Cook, Jeffrey Wilkinson, Maria C. Russell, Navneet Dhillon
Clinical Cancer Research. 2015-01-01 - 24 citationsA phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.Stacy L. Moulder, Navneet Dhillon, Chaan Ng, David S. Hong, Jennifer J. Wheler
Investigational New Drugs. 2010-10-01
Professional Memberships
- Member
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: